Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer

OBJECTIVES: The combination of chemotherapy and immune checkpoint inhibitors (chemo-ICI) has become the new standard of treatment for extensive-stage small cell lung cancer (ES-SCLC). Recently, slight changes in interstitial shadows, defined as interstitial lung abnormalities (ILA), have been identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Kiyoko, Katsurada, Naoko, Kawa, Yoshitaka, Satouchi, Miyako, Kaneshiro, Kazumi, Matsumoto, Masataka, Takamiya, Rei, Hatakeyama, Yukihisa, Dokuni, Ryota, Matsumura, Kanoko, Katsurada, Masahiro, Nakata, Kyosuke, Yoshimura, Sho, Tachihara, Motoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562781/
https://www.ncbi.nlm.nih.gov/pubmed/37822623
http://dx.doi.org/10.1016/j.heliyon.2023.e20463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562781/
https://www.ncbi.nlm.nih.gov/pubmed/37822623
http://dx.doi.org/10.1016/j.heliyon.2023.e20463

Ejemplares similares